Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU657488B2 - New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process - Google Patents
[go: Go Back, main page]

AU657488B2 - New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process - Google Patents

New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process

Info

Publication number
AU657488B2
AU657488B2 AU83708/91A AU8370891A AU657488B2 AU 657488 B2 AU657488 B2 AU 657488B2 AU 83708/91 A AU83708/91 A AU 83708/91A AU 8370891 A AU8370891 A AU 8370891A AU 657488 B2 AU657488 B2 AU 657488B2
Authority
AU
Australia
Prior art keywords
recombinants
genes
vectors
herpes viruses
plasmids used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU83708/91A
Other versions
AU8370891A (en
Inventor
Matthew Mckinley Binns
Arielle Rey-Senelonge
Michel Emile Albert Riviere
Louis Joseph Norman Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Merieux SA filed Critical Rhone Merieux SA
Publication of AU8370891A publication Critical patent/AU8370891A/en
Application granted granted Critical
Publication of AU657488B2 publication Critical patent/AU657488B2/en
Assigned to MERIAL reassignment MERIAL Request to Amend Deed and Register Assignors: RHONE MERIEUX
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU83708/91A 1990-09-07 1991-09-06 New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process Ceased AU657488B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9011146 1990-09-07
FR909011146A FR2666589B1 (en) 1990-09-07 1990-09-07 NOVEL RECOMBINANT HERPIC VIRUSES, VACCINE BASED ON SUCH RECOMBINANTS, PREPARATION METHOD THEREOF, GENES, VECTORS AND PLASMIDS USED IN THIS PROCESS.

Publications (2)

Publication Number Publication Date
AU8370891A AU8370891A (en) 1992-03-12
AU657488B2 true AU657488B2 (en) 1995-03-16

Family

ID=9400177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83708/91A Ceased AU657488B2 (en) 1990-09-07 1991-09-06 New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process

Country Status (5)

Country Link
EP (1) EP0477056A1 (en)
JP (1) JPH05168473A (en)
AU (1) AU657488B2 (en)
CA (1) CA2050850A1 (en)
FR (1) FR2666589B1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
US5849572A (en) * 1990-10-10 1998-12-15 Regents Of The University Of Michigan HSV-1 vector containing a lat promoter
US5849571A (en) * 1990-10-10 1998-12-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Latency active herpes virus promoters and their use
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
JP3529134B2 (en) 1992-07-30 2004-05-24 アクゾ・ノベル・エヌ・ベー Recombinant feline herpesvirus vector vaccine
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
FR2719056B1 (en) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformed to express gD in vitro.
WO1996021034A1 (en) * 1994-12-30 1996-07-11 Rhone Merieux Avian recombinant live vaccine
FR2728795B1 (en) * 1994-12-30 1997-03-21 Rhone Merieux AVIAN RECOMBINANT LIVING VACCINE USING AVIAN HERPES VIRUS AS A VECTOR
FR2728794B1 (en) * 1994-12-30 1997-03-21 Rhone Merieux AVIAN RECOMBINANT VACCINE BASED ON AVIAN HERPES VIRUS, PARTICULARLY AGAINST GUMBORO DISEASE
FR2757061B1 (en) * 1996-12-16 1999-03-26 Rhone Merieux AVIAN RECOMBINANT LIVING VACCINE USING AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS AS A VECTOR
WO2013057235A1 (en) 2011-10-21 2013-04-25 Intervet International B.V. Recombinant nonpathogenic mdv vector providing multivalent immunity
CA3206983A1 (en) 2011-10-21 2013-04-25 Intervet International B.V. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619812B2 (en) * 1988-03-20 1992-02-06 Research Foundation For Microbial Diseases Of Osaka University, The A recombinant marek's disease virus and a vaccine
AU8143791A (en) * 1990-07-30 1992-02-06 Intervet International B.V. Recombinant marek's disease virus
AU633663B2 (en) * 1989-12-04 1993-02-04 Intervet International B.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0434721B1 (en) * 1988-09-13 2000-03-15 Merial Viral nucleotide sequences

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619812B2 (en) * 1988-03-20 1992-02-06 Research Foundation For Microbial Diseases Of Osaka University, The A recombinant marek's disease virus and a vaccine
AU633663B2 (en) * 1989-12-04 1993-02-04 Intervet International B.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
AU8143791A (en) * 1990-07-30 1992-02-06 Intervet International B.V. Recombinant marek's disease virus

Also Published As

Publication number Publication date
JPH05168473A (en) 1993-07-02
CA2050850A1 (en) 1992-03-08
AU8370891A (en) 1992-03-12
FR2666589A1 (en) 1992-03-13
FR2666589B1 (en) 1994-08-05
EP0477056A1 (en) 1992-03-25

Similar Documents

Publication Publication Date Title
AU657488B2 (en) New recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process
USD361382S (en) Dental material curing apparatus
AU4325089A (en) Viral vaccines
IL110284A0 (en) Viral vectors and their use in gene therapy
AU2371692A (en) Recombinant hepatitis a virus vaccine
AU1768192A (en) Rna delivery vector
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
AU7097494A (en) Envelope fusion vectors for use in gene delivery
EP0347365A3 (en) Hiv-2 virus variants
FR2712603B1 (en) Recombinant viruses, preparation and use in gene therapy.
CA2189882A1 (en) Papillomavirus vaccines
AU7442996A (en) Recombinant herpes virus vectors for expression in neuronal cells
AU1927797A (en) Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
AU6037396A (en) Recombinant feline immunodeficiency vaccines produced in bac ulovirus
AU600130B2 (en) New, color pure iron oxide pigments, a process for their preparation and their use
FR2712602B1 (en) Recombinant viruses, preparation and use in gene therapy.
GB9023352D0 (en) Vaccinia vectors,vaccinia genes and expression products thereof
AU654662B2 (en) Virus/herbicide resistance genes process for producing same and their use
AU5848390A (en) Self-assembled, defective, non-self-propagating viral particles
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
AU5679394A (en) Hepatitis b virus vaccines
CA2148369A1 (en) Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof
EP0527704A3 (en) Dyestuffs, process for their preparation and the use thereof
ZA907656B (en) A dna sequence,an anther-specific promoter and the use thereof
AU5836390A (en) Human lymphoma-associated virus

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired